-
A new agent with a unique mechanism of action has been approved for the treatment of chronic constipation.
-
Prostate cancer is one of the leading causes of cancer in men, both in this country and in Europe. Due to the introduction of the prostate specific antigen blood test (PSA test), the ability to diagnose prostate cancer well before signs or symptoms of the disease develop has been realized. Following its introduction, the PSA was endorsed widely and recommended by many major public health organizations as a useful screening test.
-
-
FDA Recommends Approval of Muraglitazar, But May Need To Reconsider; Which Antipsychotics Are More Dangerous?; Should CPOE Undergo Evaluation?; New Treatment for Tennis Elbow; FDA Actions
-
Managing cardiac arrhythmias is a unique and complex challenge in the primary care setting. The clinician must balance proper initial assessment, long-term management schemes and effective acute and chronic treatment approaches with appropriate triage to a cardiac specialist and/or an electrophysiologist. The treating clinician must be able to diagnose the arrhythmia (if possible), understand the risks to the patients, and plan an acceptable therapeutic strategy. Available treatment options are evolving rapidly.
-
-
On my first walk through a redwood forest after moving to California, I came across numerous slimy yellow creatures along the trail that looked like snails without shells. These were banana slugs, creatures that are currently the official mascots of the University of Califonia, Santa Cruz.
-
-
Can Plavix Add to the Efficacy of Aspirin?; Prevention of Hypertension?; Estrogen Alternatives; FDA Actions
-
As part of the California Encephalitis Project (CEP), more than 250 serum samples from selected patients were screened for antibodies to amebic pathogens, particularly Balamuthia mandrillaris. Overall, the CEP has tested samples for > 1800 cases submitted for extensive testing in attempts to determine the etiology of encephalitis in patients without severe immunocompromise.